Cargando…

Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis

SIMPLE SUMMARY: Cancer associated cachexia and loss of skeletal muscle mass is a negative prognostic marker for survival. Temporal muscle thickness (TMT) is an easily accessible parameter that has been suggested as a prognostic marker in glioblastoma. In this multicenter study we retrospectively ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Wende, Tim, Kasper, Johannes, Prasse, Gordian, Glass, Änne, Kriesen, Thomas, Freiman, Thomas M., Meixensberger, Jürgen, Henker, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615813/
https://www.ncbi.nlm.nih.gov/pubmed/34830766
http://dx.doi.org/10.3390/cancers13225610
_version_ 1784604196375363584
author Wende, Tim
Kasper, Johannes
Prasse, Gordian
Glass, Änne
Kriesen, Thomas
Freiman, Thomas M.
Meixensberger, Jürgen
Henker, Christian
author_facet Wende, Tim
Kasper, Johannes
Prasse, Gordian
Glass, Änne
Kriesen, Thomas
Freiman, Thomas M.
Meixensberger, Jürgen
Henker, Christian
author_sort Wende, Tim
collection PubMed
description SIMPLE SUMMARY: Cancer associated cachexia and loss of skeletal muscle mass is a negative prognostic marker for survival. Temporal muscle thickness (TMT) is an easily accessible parameter that has been suggested as a prognostic marker in glioblastoma. In this multicenter study we retrospectively analyzed a cohort of 335 patients with newly diagnosed glioblastoma for their overall survival (OS) and TMT. Although previous studies found TMT to be an independent prognostic marker for OS, we could not reproduce these results. Instead, TMT seems to be a surrogate parameter for other epidemiological data. ABSTRACT: Background: Reduced temporal muscle thickness (TMT) has been discussed as a prognostic marker in IDH-wildtype glioblastoma. This retrospective multicenter study was designed to investigate whether TMT is an independent prognostic marker in newly diagnosed glioblastoma. Methods: TMT was retrospectively measured in 335 patients with newly diagnosed glioblastoma between 1 January 2014 and 31 December 2019 at the University Hospitals of Leipzig and Rostock. The cohort was dichotomized by TMT and tested for association with overall survival (OS) after 12 months by multivariate proportional hazard calculation. Results: TMT of 7.0 mm or more was associated with increased OS (46.3 ± 3.9% versus 36.6 ± 3.9%, p > 0.001). However, the sub-groups showed significant epidemiological differences. In multivariate proportional hazard calculation, patient age (HR 1.01; p = 0.004), MGMT promoter status (HR 0.76; p = 0.002), EOR (HR 0.61), adjuvant irradiation (HR 0.24) and adjuvant chemotherapy (HR 0.40; all p < 0.001) were independent prognostic markers for OS. However, KPS (HR 1.00, p = 0.31), BMI (HR 0.98, p = 0.11) and TMT (HR 1.06; p = 0.07) were not significantly associated with OS. Conclusion: TMT has not appeared as a statistically independent prognostic marker in this cohort of patients with newly diagnosed IDH-wildtype glioblastoma.
format Online
Article
Text
id pubmed-8615813
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86158132021-11-26 Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis Wende, Tim Kasper, Johannes Prasse, Gordian Glass, Änne Kriesen, Thomas Freiman, Thomas M. Meixensberger, Jürgen Henker, Christian Cancers (Basel) Article SIMPLE SUMMARY: Cancer associated cachexia and loss of skeletal muscle mass is a negative prognostic marker for survival. Temporal muscle thickness (TMT) is an easily accessible parameter that has been suggested as a prognostic marker in glioblastoma. In this multicenter study we retrospectively analyzed a cohort of 335 patients with newly diagnosed glioblastoma for their overall survival (OS) and TMT. Although previous studies found TMT to be an independent prognostic marker for OS, we could not reproduce these results. Instead, TMT seems to be a surrogate parameter for other epidemiological data. ABSTRACT: Background: Reduced temporal muscle thickness (TMT) has been discussed as a prognostic marker in IDH-wildtype glioblastoma. This retrospective multicenter study was designed to investigate whether TMT is an independent prognostic marker in newly diagnosed glioblastoma. Methods: TMT was retrospectively measured in 335 patients with newly diagnosed glioblastoma between 1 January 2014 and 31 December 2019 at the University Hospitals of Leipzig and Rostock. The cohort was dichotomized by TMT and tested for association with overall survival (OS) after 12 months by multivariate proportional hazard calculation. Results: TMT of 7.0 mm or more was associated with increased OS (46.3 ± 3.9% versus 36.6 ± 3.9%, p > 0.001). However, the sub-groups showed significant epidemiological differences. In multivariate proportional hazard calculation, patient age (HR 1.01; p = 0.004), MGMT promoter status (HR 0.76; p = 0.002), EOR (HR 0.61), adjuvant irradiation (HR 0.24) and adjuvant chemotherapy (HR 0.40; all p < 0.001) were independent prognostic markers for OS. However, KPS (HR 1.00, p = 0.31), BMI (HR 0.98, p = 0.11) and TMT (HR 1.06; p = 0.07) were not significantly associated with OS. Conclusion: TMT has not appeared as a statistically independent prognostic marker in this cohort of patients with newly diagnosed IDH-wildtype glioblastoma. MDPI 2021-11-10 /pmc/articles/PMC8615813/ /pubmed/34830766 http://dx.doi.org/10.3390/cancers13225610 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wende, Tim
Kasper, Johannes
Prasse, Gordian
Glass, Änne
Kriesen, Thomas
Freiman, Thomas M.
Meixensberger, Jürgen
Henker, Christian
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
title Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
title_full Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
title_fullStr Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
title_full_unstemmed Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
title_short Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
title_sort newly diagnosed idh-wildtype glioblastoma and temporal muscle thickness: a multicenter analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615813/
https://www.ncbi.nlm.nih.gov/pubmed/34830766
http://dx.doi.org/10.3390/cancers13225610
work_keys_str_mv AT wendetim newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis
AT kasperjohannes newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis
AT prassegordian newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis
AT glassanne newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis
AT kriesenthomas newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis
AT freimanthomasm newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis
AT meixensbergerjurgen newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis
AT henkerchristian newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis